Bioeq’s Lucentis Biosimilar Is Given EU Go-Ahead

Launch Dates And Financial Terms Of A Marketing Deal With Teva Remain Under Wraps

Close-up of woman's eye, with light falling on retina
The Ranivisio ranibizumab biosimilar has been formally approved by the European Commission • Source: Shutterstock

More from Biosimilars

More from Products